This is an important topic for pharmacists and health care providers who see people with kidney disease. This module will cover the evaluation of kidney function part 2, focusing on the application of the race-less eGFR equation to stage Chronic Kidney Disease, evaluate when evidence-based medication therapy is warranted and determine a drug dosing regimen. It is recommended to review Evaluation of Kidney Function – Part 1: Use of Race-Less eGFR before taking this module.

Estimated glomerular filtration rate (eGFR) equations are used for kidney disease staging, to assess kidney disease progression, and drug dosing. Which equation to use is a controversial area. This module will discuss the newest equations that removed race as a variable.. This module focuses on the basis for these changes, compares accuracy of these new equations to the older equations and demonstrates the rationale for using non-indexed results from this new equation for drug-related decision making.

The prevalence of Chronic Kidney Disease (CKD) is rising in the United States. National efforts have been implemented to improve the quality of care and outcomes of people with CKD. For the first time in decades, there are exciting new therapies available that have been proven to slow the progression of CKD. This module on Chronic Kidney Disease and Management will discuss the evaluation of kidney function, management of CKD and opportunities for Pharmacists; and you will apply concepts to a patient case.